Evidence map›Paper›PMID 42671724›Full record

ArticleImmunologic research2026

A novel FLNA p.Pro2469Ser variant is associated with impaired T and NK cell function and immune dysregulation.

Şerife Erdem, Ayşenur Paç Kısaarslan, Mustafa Burak Acar, Muhammet Ensar Doğan, Sümeyra Özdemir Çiçek, Pınar Garipcin, Şerife Ayaz Güner, Alper Özcan, Şule Haskoloğlu, Benhur Şirvan Çetin and 9 more

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Immunologic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Şerife ErdemDepartment of Immunology, School of Medicine, Kırşehir Ahi Evran University, Kırşehir, Türkiye.
Ayşenur Paç KısaarslanDepartment of Pediatrics, Division of Pediatric Rheumatology, Erciyes University School of Medicine, Kayseri, Türkiye. apkisaarslan@erciyes.edu.tr.ORCID http://orcid.org/0000-0002-1800-9922
Mustafa Burak AcarBetül-Ziya Eren Genome and Stem Cell Center (GENKÖK), Erciyes University, Kayseri, Türkiye.
Muhammet Ensar DoğanDepartment of Medical Genetics, Kayseri City Hospital, Kayseri, Türkiye.
Sümeyra Özdemir ÇiçekDepartment of Pediatrics, Division of Pediatric Rheumatology, Erciyes University School of Medicine, Kayseri, Türkiye.
Pınar GaripcinDepartment of Pediatrics, Division of Pediatric Rheumatology, Erciyes University School of Medicine, Kayseri, Türkiye.
Şerife Ayaz GünerDepartment of Molecular Biology and Genetics, Izmir Institute of Technology, Izmir, Türkiye.
Alper ÖzcanDivision of Pediatric Hematology and Oncology, Department of Pediatrics, School of Medicine, Erciyes University, Kayseri, Türkiye.
Şule HaskoloğluDivision of Pediatric Immunology and Allergy and Hematopoietic Stem Cell Transplantation Unit, Department of Pediatrics, School of Medicine, Ankara University, Ankara, Türkiye.
Benhur Şirvan ÇetinDivision of Pediatric Infectious Diseases, Department of Pediatrics, School of Medicine, Erciyes University, Kayseri, Türkiye.
Derya AltayDivision of Pediatric Gastroenterology, Department of Pediatrics, School of Medicine, Erciyes University, Kayseri, Türkiye.
Mehmet KöseDivision of Pediatric Pulmonology, Department of Pediatrics, School of Medicine, Erciyes University, Kayseri, Türkiye.
Buket Daldaban SarıcaDivision of Pediatric Gastroenterology, Kayseri City Hospital, Kayseri, Türkiye.
Serkan BelkayaDepartment of Molecular Biology and Genetics, School of Science, Bilkent University, Ankara, Türkiye.
Kemal Erdem BaşaranBetül-Ziya Eren Genome and Stem Cell Center (GENKÖK), Erciyes University, Kayseri, Türkiye.
Figen DoğuDivision of Pediatric Immunology and Allergy and Hematopoietic Stem Cell Transplantation Unit, Department of Pediatrics, School of Medicine, Ankara University, Ankara, Türkiye.
Kamile Aydan İkincioğullarıDivision of Pediatric Immunology and Allergy and Hematopoietic Stem Cell Transplantation Unit, Department of Pediatrics, School of Medicine, Ankara University, Ankara, Türkiye.
Ekrem ÜnalDepartment of Nursing, School of Health Sciences, Hasan Kalyoncu University, Gaziantep, Türkiye. drekremunal@yahoo.com.tr.ORCID http://orcid.org/0000-0002-2691-4826
Ahmet EkenDepartment of Medical Biology, Erciyes University School of Medicine, Kayseri, 38030, Türkiye. ahmet.eken@gmail.com.ORCID http://orcid.org/0000-0002-5816-0686

Funding

BA BAGEP 2022BAP TYG-2023-13110TUBA GEBIP 2021Türkiye Bilimsel ve Teknolojik Araştırma Kurumu 221S883
6 · The paper itself

Abstract

FLNA encodes filamin A, a ubiquitously expressed actin-binding cytoskeletal protein that cross-links actin filaments and links them to membrane-associated signaling complexes. Although FLNA has been implicated in T-cell signaling and regulatory T-cell development in murine models, its role in human immune-cell function remains incompletely understood. Here, we investigated the immunological phenotype associated with a novel hemizygous FLNA variant identified in a pediatric patient presenting with recurrent infections and inflammatory manifestations. Whole-exome sequencing revealed a hemizygous c.7405C>T (p.Pro2469Ser) variant in FLNA, which was confirmed by Sanger sequencing. Its potential impact on immune-cell function and cytoskeletal organization was evaluated using confocal microscopy, flow cytometry, and molecular assays. Patient-derived T cells showed impaired activation and proliferation following CD3/CD28 and IL-2 stimulation, accompanied by reduced CD25 and CD69 upregulation. CD4+ T cells also exhibited reduced IFN-γ, TNF-α, and IL-2 production after stimulation. Despite elevated basal phospho-STAT5 levels, IL-2-induced STAT5 phosphorylation and TCR-associated signaling responses, including pZAP70, pLCK, and p38 MAPK activation, were attenuated. Confocal imaging together with image-based quantification demonstrated altered cortical cytoskeletal organization in patient T cells despite preserved FLNA expression. In parallel, NK cells showed impaired activation responses and reduced cytotoxic activity under the assay conditions used. Increased apoptosis was observed in CD4⁺, CD8⁺, and NK-cell populations. Inflammatory cytokines were elevated in plasma and colonic tissue, whereas colonic ZO-1 and FLNA expression were reduced. Collectively, these findings indicate that the FLNA p.Pro2469Ser variant is associated with altered immune-cell signaling, disturbed cortical cytoskeletal organization, and immune dysregulation. This study expands the phenotypic spectrum linked to FLNA variants and supports a role for filamin A in human immune-cell regulation.

Indexed as

FilaminsKiller Cells, NaturalT-LymphocytesCells, CulturedCytokinesFemaleHumansLymphocyte ActivationSignal TransductionCytokinesFilaminsFLNA protein, humanActinopathyFilamin aFLNA

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.